0001058330 false 2021 Q2 12/31 0001058330 2021-01-01 2021-06-30 0001058330 2021-08-20 0001058330 2021-06-30 0001058330 2020-12-31 0001058330 2021-04-01 2021-06-30 0001058330 2020-04-01 2020-06-30 0001058330 2020-01-01 2020-06-30 0001058330 us-gaap:PreferredStockMember 2020-03-31 0001058330 roag:PreferredStockDMember 2020-03-31 0001058330 roag:PreferredStockEMember 2020-03-31 0001058330 us-gaap:CommonStockMember 2020-03-31 0001058330 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001058330 us-gaap:RetainedEarningsMember 2020-03-31 0001058330 2020-03-31 0001058330 us-gaap:PreferredStockMember 2020-04-01 2020-06-30 0001058330 roag:PreferredStockDMember 2020-04-01 2020-06-30 0001058330 roag:PreferredStockEMember 2020-04-01 2020-06-30 0001058330 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001058330 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001058330 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001058330 us-gaap:PreferredStockMember 2020-06-30 0001058330 roag:PreferredStockDMember 2020-06-30 0001058330 roag:PreferredStockEMember 2020-06-30 0001058330 us-gaap:CommonStockMember 2020-06-30 0001058330 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001058330 us-gaap:RetainedEarningsMember 2020-06-30 0001058330 2020-06-30 0001058330 us-gaap:PreferredStockMember 2021-03-31 0001058330 roag:PreferredStockDMember 2021-03-31 0001058330 roag:PreferredStockEMember 2021-03-31 0001058330 us-gaap:CommonStockMember 2021-03-31 0001058330 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001058330 us-gaap:RetainedEarningsMember 2021-03-31 0001058330 2021-03-31 0001058330 us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0001058330 roag:PreferredStockDMember 2021-04-01 2021-06-30 0001058330 roag:PreferredStockEMember 2021-04-01 2021-06-30 0001058330 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001058330 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001058330 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001058330 us-gaap:PreferredStockMember 2021-06-30 0001058330 roag:PreferredStockDMember 2021-06-30 0001058330 roag:PreferredStockEMember 2021-06-30 0001058330 us-gaap:CommonStockMember 2021-06-30 0001058330 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001058330 us-gaap:RetainedEarningsMember 2021-06-30 0001058330 us-gaap:PreferredStockMember 2019-12-31 0001058330 roag:PreferredStockDMember 2019-12-31 0001058330 roag:PreferredStockEMember 2019-12-31 0001058330 us-gaap:CommonStockMember 2019-12-31 0001058330 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001058330 us-gaap:RetainedEarningsMember 2019-12-31 0001058330 2019-12-31 0001058330 us-gaap:PreferredStockMember 2020-01-01 2020-06-30 0001058330 roag:PreferredStockDMember 2020-01-01 2020-06-30 0001058330 roag:PreferredStockEMember 2020-01-01 2020-06-30 0001058330 us-gaap:CommonStockMember 2020-01-01 2020-06-30 0001058330 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-06-30 0001058330 us-gaap:RetainedEarningsMember 2020-01-01 2020-06-30 0001058330 us-gaap:PreferredStockMember 2020-12-31 0001058330 roag:PreferredStockDMember 2020-12-31 0001058330 roag:PreferredStockEMember 2020-12-31 0001058330 us-gaap:CommonStockMember 2020-12-31 0001058330 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001058330 us-gaap:RetainedEarningsMember 2020-12-31 0001058330 us-gaap:PreferredStockMember 2021-01-01 2021-06-30 0001058330 roag:PreferredStockDMember 2021-01-01 2021-06-30 0001058330 roag:PreferredStockEMember 2021-01-01 2021-06-30 0001058330 us-gaap:CommonStockMember 2021-01-01 2021-06-30 0001058330 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-06-30 0001058330 us-gaap:RetainedEarningsMember 2021-01-01 2021-06-30 0001058330 us-gaap:SeriesDPreferredStockMember 2021-01-01 2021-06-30 0001058330 us-gaap:CommonStockMember 2021-01-01 2021-06-30 0001058330 2021-04-01 2021-04-07 0001058330 roag:ConvertibleNote4Member 2021-06-30 0001058330 roag:ConvertibleNote7Member 2021-06-30 0001058330 roag:ConvertibleNote9Member 2021-06-30 0001058330 roag:ConvertibleNote10Member 2021-06-30 0001058330 roag:ConvertibleNote11Member 2021-06-30 0001058330 2020-01-01 2020-12-31 0001058330 srt:MinimumMember 2021-01-01 2021-06-30 0001058330 srt:MaximumMember 2021-01-01 2021-06-30 0001058330 srt:MinimumMember 2020-01-01 2020-12-31 0001058330 srt:MaximumMember 2020-01-01 2020-12-31 0001058330 us-gaap:FairValueInputsLevel1Member 2020-12-31 0001058330 us-gaap:FairValueInputsLevel2Member 2020-12-31 0001058330 us-gaap:FairValueInputsLevel3Member 2020-12-31 0001058330 us-gaap:FairValueInputsLevel1Member 2021-06-30 0001058330 us-gaap:FairValueInputsLevel2Member 2021-06-30 0001058330 us-gaap:FairValueInputsLevel3Member 2021-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~March~~June 3130, 2021

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________________ to ________________.

Commission File Number 00-24723

ROGUE ONE, INC.

(Exact name of registrant as specified in its charter)

Nevada

88-0393257

(State or other jurisdiction of

Incorporation or organization)

(I.R.S. Employer Identification No.)

3416 Shadybrook Drive

Midwest City, Oklahoma 73110

(Address of principal executive offices)

(405) 733-1567

(Issuer’s Telephone Number)

Securities registered pursuant to Section 12(b) of the Act: None

Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

	Large accelerated filer ☐	Accelerated filer ☐
	Non-accelerated filer ☒	Smaller reporting company ☒
		Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~May~~August 20, 2021, the Registrant had ~~119~~128,~~942~~432,~~288~~ 131 shares of Common Stock issued and outstanding.

TABLE OF CONTENTS

		Page
Part I – FINANCIAL INFORMATION
Item 1.	Financial Statements	34
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	1420
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	1623
Item 4.	Controls and Procedures	1623
Part II – OTHER INFORMATION
Item 1.	Legal Proceedings	1725
Item 1A.	Risk Factors	1725
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	1725
Item 3.	Defaults upon Senior Securities	1725
Item 4.	Mine safety disclosure	1725
Item 5.	Other Information	1725
Item 6.	Exhibits	1725

CAUTIONARY STATEMENT ON FORWARD-LOOKING INFORMATION

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based upon our current assumptions, expectations and beliefs concerning future developments and their potential effect on our business. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “approximately,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other comparable terminology, although the absence of these words does not necessarily mean that a statement is not forward-looking. This information may involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from the future results, performance or achievements expressed or implied by any forward-looking statements.

All forward-looking statements speak only as of the date of this report. We undertake no obligation to update any forward-looking statements or other information contained herein. Stockholders and potential investors should not place undue reliance on these forward-looking statements. Although we believe that our plans, intentions and expectations reflected in or suggested by the forward-looking statements in this report are reasonable, we cannot assure stockholders and potential investors that these plans, intentions or expectations will be achieved. We disclose important factors that could cause our actual results to differ materially from expectations under “Risk Factors” in our annual report on Form 10-K. These cautionary statements qualify all forward-looking statements attributable to us or persons acting on our behalf.

These forward-looking statements represent our intentions, plans, expectations, assumptions and beliefs about future events and are subject to risks, uncertainties and other factors. Many of those factors are outside of our control and could cause actual results to differ materially from the results expressed or implied by those forward-looking statements. Considering these risks, uncertainties and assumptions, the events described in the forward-looking statements might not occur or might occur to a different extent or at a different time than we have described. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of the Quarterly Report on Form 10-Q. All subsequent written and oral forward-looking statements concerning other matters addressed in this Quarterly Report on Form 10-Q and attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this Quarterly Report on Form 10-Q.

Except to the extent required by law, we undertake no obligation to update or revise any forward-looking statements, whether because of new information, future events, a change in events, conditions, circumstances or assumptions underlying such statements, or otherwise.

Part I. FINANCIAL INFORMATION

Item 1. Financial Statements

FRESH PROMISE FOODS, INC.

Consolidated Balance Sheets (Unaudited)

	March 31,			December 31,
	2021			2020
ASSETS
Current assets:
Cash and cash equivalents	$	2,129		$	111
Total current assets		2,129			111
Other noncurrent assets		80,000			—
Total assets	$	82,129		$	111
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
Accounts payable	$	165,466		$	165,466
Accrued liabilities		1,397,693			1,554,862
Convertible notes payable, current		1,576,254			1,559,803
Derivative liabilities		2,460,803			2,298,820
Related party payables		4,505			4,505
Total current liabilities		5,604,721			5,583,456
Total liabilities		5,604,721			5,583,456
Commitments and contingencies		—			—
Stockholders' Deficit:
Preferred stock - Series A, $0.00001 par value. 69,999,990 shares authorized; 10,000,000 shares
issued and outstanding as of March 31, 2021 and December 31, 2020, respectively		100			100
Preferred stock - Series D, $0.00001 par value. 1 share authorized; zero shares
issued and outstanding as of March 31, 2021 and December 31, 2020, respectively		—			—
Preferred stock - Series E, $0.00001 par value. 50 shares authorized; 48 and 20 shares
issued and outstanding as of March 31, 2021 and December 31, 2020, respectively		—			—
Common stock, $0.001 par value. 1,000,000,000 shares authorized; 104,141,859 and 101,925,194 shares
issued and outstanding as of March 31, 2021 and December 31, 2020, respectively		104,142			101,925
Additional paid-in capital		9,573,541			8,984,757
Accumulated deficit		(15,200,375	)		(14,670,127	)
Total stockholders' deficit		(5,522,592	)		(5,583,345	)
Total liabilities and stockholders' deficit	$	82,129		$	111

The accompanying notes are an integral part of the consolidated financial statements.

FRESH PROMISE FOODS, INC.

Consolidated Statements of Operations (Unaudited)

	Three Months Ended March 31,			Three Months Ended March 31,
	2021			2020
Sales	$	—		$	—
Cost of goods sold		—			—
Gross profit		—			—
Operating expenses
Compensation and benefits		57,000			15,000
General and administrative expenses		9,482			2,174
Professional fees		8,500			58,500
Stock based compensation		215,000			—
Total operating expenses		289,982			75,674
Loss from operations		(289,982	)		(75,674	)
Other income (expenses)
Gain (loss) on change in value of derivative liabilities		(161,983	)		113,585
Interest expense, net		(78,283	)		(55,412	)
Total other income (expense)		(240,266	)		58,173
Loss before income taxes		(530,248	)		(17,501	)
Provision for income taxes (benefit)		—			—
Net loss		(530,248	)		(17,501	)
Basic and diluted loss per common share
Net loss	$	(0.01	)	$	(0.00	)
Weighted-average number of common shares outstanding:
Basic and diluted		102,120,193			86,381,861

The accompanying notes are an integral part of the consolidated financial statements.

FRESH PROMISE FOODS, INC.

Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

																				Additional						Total
	Preferred Stock - Series A				Preferred Stock - Series D				Preferred Stock - Series E					Common Stock						Paid-in			Retained			Stockholders'
	Shares		Value		Shares		Value		Shares			Value		Shares			Value			Capital			Earnings			Equity
Balance, December 31, 2019		10,000,000	$	100		1	$	—		12		$	—		86,381,861		$	86,383		$	8,894,472		$	(14,103,906	)	$	(5,122,952	)
Net loss		—		—		—		—		—			—		—			—			—			(17,501	)		(17,501	)
Balance, March 31, 2020		10,000,000	$	100		1	$	—		12		$	—		86,381,861		$	86,382		$	8,894,472		$	(14,121,407	)	$	(5,140,453	)
																					Additional						Total
		Preferred Stock - Series A				Preferred Stock - Series D				Preferred Stock - Series E					Common Stock						Paid-in			Retained			Stockholders'
		Shares		Value		Shares		Value		Shares			Value		Shares			Value			Capital			Earnings			Equity
Balance, December 31, 2020		10,000,000	$	100		—	$	—		24		$	—		101,925,194		$	101,925		$	8,984,757		$	(14,670,127	)	$	(5,583,345	)
Net loss		—		—		—		—		—			—		—			—			—			(530,248	)		(530,248	)
Conversion of Series E preferred stock for common stock		—		—		—		—		(3	)		—		1,200,000			1,200			(1,200	)		—			—
Issuance of Series E preferred stock in connection with sales made under
private or public offerings		—		—		—		—		2			—		—			—			40,000			—			40,000
Issuance of Series E preferred and common stock as
compensation to employees, officers and/or directors		—		—		—		—		6			—		100,000			100			89,900			—			90,000
Issuance of Series E preferred and common stock as compensation
to employees, officers and/or directors		—		—		—		—		15			—		250,000			250			224,750			—			225,000
Issuance of Series E preferred stock in exchange for fees and services rendered		—		—		—		—		4			—		—			—			125,000			—			125,000
Issuance of common stock in connection with sales made under
private or public offerings		—		—		—		—		—			—		1,666,667			1,667			98,333			—			100,000
Return of common stock issued in connection with the
acquisition of a business		—		—		—		—		—			—		(2,000,000	)		(2,000	)		2,000			—			—
Conversion of convertible notes payable and accrued interest into
common stock		—		—		—		—		—			—		999,999			1,000			10,001			—			11,001
Balance, March 31, 2021		10,000,000	$	100		—	$	—		48		$	—		104,141,859		$	104,142		$	9,573,541		$	(15,200,375	)	$	(5,522,592	)

The accompanying notes are an integral part of the consolidated financial statements.

FRESH PROMISE FOODS, INC.

Consolidated Statements of Cash Flows (Unaudited)

Three Months Ended March 31,	Three Months Ended March 31,
	2021			2020
Cash flows from operating activities:
Net loss	$	(530,248	)	$	(17,501	)
Adjustments to reconcile net loss to cash used in operating activities:
Amortization of debt discount		21,300			—
Preferred stock issued as compensation to employees, officers and/or directors		90,000			—
Preferred stock issued in exchange for fees and services		125,000			—
(Gain) loss on change in value of derivative liabilities		161,983			(113,585	)
Changes in operating assets and liabilities:
Accrued liabilities		73,983			128,912
Other noncurrent assets		(80,000	)		—
Related party payables		—			2,224
Net cash provided by (used in) operating activities		(137,982	)		50
Cash flows from investing activities:
Investment		—			—
Net cash provided by (used in) investing activities		—			—
Cash flows from financing activities:
Proceeds from issuance of common stock		140,000			—
Net cash provided by financing activities		140,000			—
Net increase in cash and cash equivalents		2,018			50
Cash and cash equivalents at beginning of period		111			19
Cash and cash equivalents at end of period	$	2,129		$	69
Supplemental disclosure of cash flow information:
Cash paid for interest	$	—		$	—
Cash paid for income taxes	$	—		$	—
Supplemental disclosure of non-cash investing and financing activities:
Common stock issued to reduce convertible notes payable	$	11,001		$	—
Series E preferred stock issued in lieu of cash for accrued officer compensation	$	225,000		$	—

The accompanying notes are an integral part of the consolidated financial statements.

ROGUE ONE, INC.

~~NOTES TO THE CONSOLIDATED~~Condensed ~~FINANCIAL~~Consolidated ~~STATEMENTS~~Balance Sheets (~~UNAUDITED~~Unaudited)


	June 30,			December 31,
	2021			2020

ASSETS
Current assets:
Cash and cash equivalents	$	216		$	111
Total current assets		216			111
Other noncurrent assets		145,000			—
Total assets	$	145,216		$	111

LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
Accounts payable	$	165,466		$	165,466
Accrued liabilities		990,078			1,554,862
Convertible notes payable, current		1,407,701			1,559,803
Derivative liabilities		2,747,418			2,298,820
Promissory notes payable		12,500			—
Related party payables		6,055			4,505
Total current liabilities		5,329,218			5,583,456
Total liabilities		5,329,218			5,583,456

Commitments and contingencies		—			—

Stockholders' Deficit:
Preferred stock - Series A, $0.00001 par value. 69,999,990 shares authorized; 10,000,000 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively		100			100
Preferred stock - Series D, $0.00001 par value. 1 share authorized; zero 0 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively		—			—
Preferred stock - Series E, $0.00001 par value. 50 shares authorized; 50 and 20 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively		—			—
Common stock, $0.001 par value. 1,000,000,000 shares authorized; 123,197,371 and 101,929,993 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively		123,197			101,930
Additional paid-in capital		10,354,315			8,984,752
Accumulated deficit		(15,661,614	)		(14,670,127	)
Total stockholders' deficit		(5,184,002	)		(5,583,345	)
Total liabilities and stockholders' deficit	$	145,216		$	111

The accompanying notes are an integral part of the condensed consolidated financial statements..

-4-

ROGUE ONE, INC.

Condensed Consolidated Statements of Operations (Unaudited )


	Three Months Ended June 30,			Three Months Ended June 30,			Six Months Ended June 30,			Six Months Ended June 30,
	2021			2020			2021			2020

Sales	$	—		$	—		$	—		$	—
Cost of goods sold		—			—			—			—
Gross profit		—			—			—			—
Operating expenses
Compensation and benefits		57,000			15,000			114,000			30,000
General and administrative expenses		30,137			15,577			39,619			17,751
Professional fees		20,605			9,435			29,105			67,935
Stock based compensation		—			—			215,000			—
Total operating expenses		107,742			40,012			397,724			115,686
Loss from operations		(107,742	)		(40,012	)		(397,724	)		(115,686	)
Other income (expenses)
Derivative liability expense		—			(102,248	)		—			(102,248	)
Loss on change in value of derivative liabilities		(286,615	)		(2,706,281	)		(448,598	)		(2,592,696	)
Interest expense, net		(66,882	)		(67,529	)		(145,165	)		(122,941	)
Total other income (expense)		(353,497	)		(2,876,058	)		(593,763	)		(2,817,885	)
Loss before income taxes		(461,239	)		(2,916,070	)		(991,487	)		(2,933,571	)
Provision for income taxes (benefit)		—			—			—			—
Net loss		(461,239	)		(2,916,070	)		(991,487	)		(2,933,571	)

Basic and diluted loss per common share
Net loss	$	(0.00	)	$	(0.03	)	$	(0.01	)	$	(0.03	)

Weighted-average number of common shares outstanding:
Basic and diluted		116,934,786			96,515,927			109,572,911			87,098,894

The accompanying notes are an integral part of the condensed consolidated financial statements.

-5-

ROGUE ONE, INC.

Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)


	Preferred Stock - Series A				Preferred Stock - Series D					Preferred Stock - Series E				Common Stock				Additional Paid-in			Accumulated			Total Stockholders'
	Shares		Value		Shares			Value		Shares		Value		Shares		Value		Capital			Deficit			Deficit

Balance, March 31, 2020		10,000,000	$	100		1		$	—		12	$	—		86,386,660	$	86,387	$	8,894,467		$	(14,121,407	)	$	(5,140,453	)

Net loss		—		—		—			—		—		—		—		—		—			(2,916,070	)		(2,916,070	)
Conversion of Series D preferred stock for common stock		—		—		(1	)		—		—		—		870,000		8,700		(8,700	)		—			—
Issuance of Series E preferred stock to an officer as compensation		—		—		—			—		8		—		—		—		17,500			—			17,500

Balance, June 30, 2020		10,000,000	$	100		—		$	—		20	$	—		87,256,660	$	95,087	$	8,903,267		$	(17,037,477	)	$	(8,039,023	)


		Preferred Stock - Series A				Preferred Stock - Series D					Preferred Stock - Series E				Common Stock				Additional Paid-in			Accumulated			Total Stockholders'
		Shares		Value		Shares			Value		Shares		Value		Shares		Value		Capital			Deficit			Deficit

Balance, March 31, 2021		10,000,000	$	100		—		$	—		48	$	—		104,146,658	$	104,147	$	9,573,536		$	(15,200,375	)	$	(5,522,592	)

Net loss		—		—		—			—		—		—		—		—		—			(461,239	)		(461,239	)

Issuance of Series E preferred stock in connection with sales made under private or public offerings		—		—		—			—		2		—		—		—		20,000			—			20,000
Issuance of common stock in connection with sales made under private or public offerings		—		—		—			—		—		—		3,250,714		3,250		96,130			—			99,380
Conversion of convertible debentures and accrued interest into common stock		—		—		—			—		—		—		15,800,000		15,800		664,649			—			680,449

Balance, June 30, 2021		10,000,000	$	100		—		$	—		50	$	—		123,197,371	$	123,197	$	10,354,315		$	(15,661,614	)	$	(5,184,002	)

The accompanying notes are an integral part of the condensed consolidated financial statements.

-6-

ROGUE ONE, INC.

Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)


	Preferred Stock - Series A				Preferred Stock - Series D					Preferred Stock - Series E					Common Stock						Additional Paid-in			Accumulated			Total Stockholders'
Six Months Ended June 30, 2020	Shares		Value		Shares			Value		Shares			Value		Shares			Value			Capital			Deficit			Deficit

Balance, December 31, 2019		10,000,000	$	100		1		$	—		12		$	—		86,386,660		$	86,387		$	8,894,467		$	(14,103,906	)	$	(5,122,952	)

Net loss		—		—		—			—		—			—		—			—			—			(2,933,571	)		(2,933,571	)
Conversion of Series D preferred stock for common stock		—		—		(1	)		—		—			—		870,000			8,700			(8,700	)		—			—
Issuance of Series E preferred stock to an officer as compensation		—		—		—			—		8			—		—			—			17,500			—			17,500

Balance, June 30, 2020		10,000,000	$	100		—		$	—		20		$	—		87,256,660		$	95,087		$	8,903,267		$	(17,037,477	)	$	(8,039,023	)


		Preferred Stock - Series A				Preferred Stock - Series D					Preferred Stock - Series E					Common Stock						Additional Paid-in			Accumulated			Total Stockholders'
Six Months Ended June 30, 2021		Shares		Value		Shares			Value		Shares			Value		Shares			Value			Capital			Deficit			Deficit

Balance, December 31, 2020		10,000,000	$	100		—		$	—		24		$	—		101,929,993		$	101,930		$	8,984,752		$	(14,670,127	)	$	(5,583,345	)

Net loss		—		—		—			—		—			—		—			—			—			(991,487	)		(991,487	)
Conversion of Series E preferred stock for common stock		—		—		—			—		(3	)		—		1,200,000			1,200			(1,200	)		—			—

Issuance of Series E preferred stock in connection with sales made under private or public offerings		—		—		—			—		4			—		—			—			60,000			—			60,000
Issuance of Series E preferred and common stock in lieu of cash for accrued compensation to employees, officers and/or directors		—		—		—			—		6			—		100,000			100			89,900			—			90,000
Issuance of Series E preferred and common stock as compensation to employees, officers and/or directors		—		—		—			—		15			—		250,000			250			224,750			—			225,000
Issuance of Series E preferred stock in exchange for fees and services rendered		—		—		—			—		4			—		—			—			125,000			—			125,000
Issuance of common stock in connection with sales made under private or public offerings		—		—		—			—		—			—		4,917,381			4,917			194,463			—			199,380
Return of common stock issued in connection with the acquisition of a business		—		—		—			—		—			—		(2,000,000	)		(2,000	)		2,000			—			—
Conversion of convertible debentures and accrued interest into common stock		—		—		—			—		—			—		16,799,999			16,800			674,650			—			691,450

Balance, June 30, 2021		10,000,000	$	100		—		$	—		50		$	—		123,197,371		$	123,197		$	10,354,315		$	(15,661,614	)	$	(5,184,002	)

The accompanying notes are an integral part of the condensed consolidated financial statements.

-7-

ROGUE ONE, INC.

Condensed Consolidated Statements of Cash Flows (Unaudited)


	Six Months Ended June 30,			Six Months Ended June 30,
	2021			2020
Cash flows from operating activities:
Net loss	$	(991,487	)	$	(2,933,571	)
Adjustments to reconcile net loss to cash used in operating activities:
Amortization of debt discount		35,000			10,933
Preferred stock issued as compensation to employees, officers and/or directors		90,000			—
Preferred stock issued in exchange for fees and services		125,000			—
Derivative expense		—			102,248
Loss on change in value of derivative liabilities		448,598			2,592,696
Changes in operating assets and liabilities:
Prepaid expenses and other current assets		(145,000	)		—
Accrued liabilities		164,565			162,807
Related party payables		1,549			4,924
Net cash used in operating activities		(271,775	)		(59,963	)

Cash flows from investing activities:
Net cash provided by (used in) investing activities		—			—

Cash flows from financing activities:
Proceeds from issuance of common stock		199,380			—
Proceeds from issuance of preferred stock		60,000			—
Proceeds from issuance of convertible notes		—			60,000
Proceeds from issuance of short term loans		12,500			—
Net cash provided by financing activities		271,880			60,000

Net increase (decrease) in cash and cash equivalents		105			37
Cash and cash equivalents at beginning of period		111			19
Cash and cash equivalents at end of period	$	216		$	56

Supplemental disclosure of cash flow information:
Cash paid for interest	$	—		$	—
Cash paid for income taxes	$	—		$	—

Supplemental disclosure of non-cash investing and financing activities:
Common stock issued to reduce convertible and promissory notes payable	$	691,450		$	—
Series E preferred stock issued in lieu of cash for accrued officer compensation	$	225,000		$	—

The accompanying notes are an integral part of the condensed consolidated financial statements.

-8-

ROGUE ONE, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 1 – NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Business

Rogue One, Inc. (“Rogue One” or the “Company”) is a consumer products and marketing company focused on the high-margin, multi-trillion-dollar alcoholic beverages sector.

On June 27, 2017, Creative Edge Nutrition, a Nevada corporation ("CEN") and Rogue One executed an asset purchase agreement whereby the Company purchased the assets and liabilities of CEN's subsidiary, Giddy Up Energy Products, Inc. ("Giddy"). As consideration, the Company agreed to exchange 47,197,601 shares of its common stock. On January 24, 2018, the Company completed the distribution of its common shares to the CEN shareholders in order to consummate the acquisition of Giddy. On December 7, 2020, the Company and Giddy entered into a Settlement Agreement, Waiver and Release of Claims whereby each party warranted and represented that they sought to fully and mutually rescind the purchase agreement dated June 27, 2017 and, in so doing, for Giddy to acquire the assets previously sold and, at the same time, for each of the parties to waive and release all claims, both known and unknown, and to indemnify and hold all other parties harmless. In addition, the parties agreed to enter into an exclusive licensing agreement for the Giddy Up brand in the category of alcoholic beverages.

On September 23, 2020, the Company entered into a Merger Agreement and Plan of Reorganization with Human Brands International, Inc., a private corporation organized pursuant to the laws of the State of Nevada (“Human Brands”), pursuant to which, at the effective time, Human Brands shareholders will exchange 100% of the equity in Human Brands in exchange for a majority controlling interest in the Company. ~~Human~~On ~~Brands~~June ~~operating~~30, ~~divisions~~2021, ~~currently~~the ~~own~~Acquisition ~~and~~Agreement ~~manage~~was ~~over~~made ~~250,000~~effective ~~agave~~pending ~~plants,~~certain ~~several~~closing ~~premium~~conditions. ~~spirit~~Under ~~brands,~~the ~~and~~terms ~~hold~~of ~~exclusive~~the ~~import~~Acquisition ~~and~~Agreement, ~~export~~the ~~rights~~Company ~~for~~agreed ato ~~variety~~issue an aggregate of ~~spirit~~45 shares ~~brands.~~of ~~Its~~its ~~core~~Series ~~foundation~~D ispreferred ~~built~~stock ~~upon~~and ~~its~~an aggregate ~~bulk~~of ~~tequila~~176,771,962 shares ~~production~~of ~~operations.~~its ~~Human~~common ~~Brands currently~~stock ~~has~~to ~~supply~~acquire ~~contracts~~all ~~with~~of the ~~well-known~~outstanding ~~tequila~~capital ~~brands,~~stock ~~celebrities~~of ~~and~~Human ~~athletes~~Brands.

-9-

Human Brands operating divisions currently own and manage over 250,000 agave plants, several premium spirit brands, and hold exclusive import and export rights for a variety of spirit brands. Its core foundation is built upon its bulk tequila production operations. Human Brands currently has supply contracts with well-known tequila brands, celebrities and athletes.

On April 7, 2021 the Company effected a 1-for-100 reverse split which as preceded by a filing of an amendment to its Articles of Incorporation that the Company completed with the Nevada Secretary of State on February 13, 2021. On April 7, 2021, the Company also amended its Articles of Incorporation to change its name to Rogue One, Inc.

Going Concern

The accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the twelve-month period following the date of these financial statements. On a consolidated basis, the Company has incurred significant operating losses since inception.

Because the Company does not expect that existing operational cash flow will be sufficient to fund presently anticipated operations, this raises substantial doubt about the Company’s ability to continue as a going concern. Therefore, the Company will need to raise additional funds and is currently exploring alternative sources of financing. Historically, the Company has raised capital through the issuance of convertible debt as a measure to finance working capital needs. The Company will be required to continue to do so until such time that its consolidated operations become profitable.

Basis of Presentation

The Company has prepared the accompanying condensed consolidated financial statements in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) and in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). The Company believes these condensed consolidated financial statements reflect all adjustments (consisting of normal, recurring adjustments) that are necessary for a fair presentation of its condensed consolidated financial position and consolidated results of operations for the periods presented.

Use of Estimates

The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on historical experience, known or expected trends and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.

Cash and Cash Equivalents

The Company considers all highly liquid investments with maturities of three months or less to be cash equivalents. The Company places its cash with a high credit quality financial institution. The Company’s account at this institution is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. At ~~March~~June 3130, 2021 and December 31, 2020, the Company did not have bank balances exceeding the FDIC insurance limit. To reduce its risk associated with the failure of such financial institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits.

7-10-

Fair Value of Financial Instruments

The Company uses the market approach to measure fair value for its financial instruments. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The respective carrying value of certain balance sheet financial instruments approximates its fair value. These financial instruments include cash, related party payables, accounts payable, accrued liabilities and short-term borrowings. Fair values were estimated to approximate carrying values for these financial instruments since they are short term in nature, and they are receivable or payable on demand.

Net Income (Loss) per Common Share

Net income (loss) per share is calculated in accordance with ASC 260, Earnings per Share. Basic net income (loss) per common share is based on the weighted average number of shares of common stock outstanding at ~~March~~June 3130, 2021 and 2020. Diluted earnings per share is calculated by dividing the Company’s net loss available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. At ~~March~~June 3130, 2021 and 2020, the Company had convertible notes outstanding that could be converted into approximately 3671,~~218~~418,~~340~~ 784 and ~~233~~356,~~771~~568,~~363~~ 069 common shares based up the closing bid price of the Company’s common stock at ~~March~~June 3130, 2021 and 2020, respectively. Shares which would result from the conversion of the convertible notes were excluded from the calculation of net loss per share for 2021 and 2020 because the effect would be anti-dilutive.

Share-Based Compensation

ASC 718, Compensation – Stock Compensation, prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

Income Taxes

The Company accounts for income taxes pursuant to the provisions of ASC 740-10, Accounting for Income Taxes, which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities.

A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized.

The Company follows the provisions of the ASC 740-10, Accounting for Uncertain Income Tax Positions. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions will be highly certain of being upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.

-11-

The Company has adopted ASC 740-10-25, Definition of Settlement, which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion of an examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. Management has not filed tax returns for the years ended December 31, 2014 through 2020.

Recent Accounting Pronouncements

Except for rules and interpretive releases of the SEC under the authority of federal securities laws and a limited number of grandfathered standards, the FASB Accounting Standards Codification™ (“ASC”) is the sole source of authoritative GAAP literature recognized by the FASB and applicable to the Company. Management has reviewed the aforementioned rules and releases and believes any effect will not have a material impact on the Company’s present or future financial statements.

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740), which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as tax basis step-up in goodwill obtained in a transaction that is not a business combination, ownership changes in investments, and interim-period accounting for enacted changes in tax law. The amendment will be effective for public companies with fiscal years beginning after December 15, 2020; early adoption is permitted. The Company is evaluating the impact of this amendment on its consolidated financial statements.

In February 2020, the FASB issued ASU 2020-02, Financial Instruments-Credit Losses (Topic 326) and Leases (Topic 842) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842), which amends the effective date of the original pronouncement for smaller reporting companies. ASU 2016-13 and its amendments will be effective for the Company for interim and annual periods in fiscal years beginning after December 15, 2022. The Company believes the adoption will modify the way the Company analyzes financial instruments, but it does not anticipate a material impact on results of operations. The Company is in the process of determining the effects adoption will have on its consolidated financial statements.

NOTE 2 – GOING CONCERN

The Company’s condensed consolidated financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating cost and allow it to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.

The Company incurred a net loss of $~~530~~991,~~248~~487 for the ~~three~~six months ended ~~March~~June 3130, 2021 and a working capital deficit of $5,~~602~~329,~~593~~ 002 at ~~March~~June 3130, 2021. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.

In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’s plan to obtain such resources for the Company include, obtaining debt or equity capital from various lenders, institutions and significant stockholders sufficient to meet its minimal operating expenses. However, management cannot provide any assurance that the Company will be successful in accomplishing any of its plans.

There is no assurance that the Company will be able to obtain sufficient additional funds when needed or that such funds, if available, will be obtainable on terms satisfactory to the Company. In addition, profitability will ultimately depend upon the level of revenues received from business operations. However, there is no assurance that the Company will attain profitability. The accompanying condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

-12-

NOTE 3 – OTHER NONCURRENT ASSETS

At ~~March~~June 3130, 2021 and December 31, 2020, other noncurrent assets were $80145,000 and $0, respectively. Other noncurrent assets are comprised solely of advances made by the Company to Human Brands International, Inc., an entity with which the Company has entered into a merger agreement and plan of reorganization. See Note 8 – Commitments and Contingencies. The advances were made to help finance capital expenditures, expand capacity and facilitate working capital needs.

NOTE 4 – CONVERTIBLE NOTES PAYABLE

The following tables set forth the components of the Company’s convertible notes at ~~March~~June 3130, 2021 and December 31, 2020:

	March 31, 2021			December 31, 2020
Schedule of convertible notes payable
Principal value of convertible notes	$	1,590,704		$	1,595,553
	June 30, 2021			December 31, 2020
Unamortized loan discounts		(14,450	)		(35,750	)
Principal value of convertible notes	$	1,409,701		$	1,595,553
Total convertible notes, net	$	1,576,254		$	1,559,803
Unamortized loan discounts		(2,000	)		(35,750	)
Total convertible notes, net	$	1,407,701		$	1,559,803

The following table sets forth a summary of change in our convertible notes payable for the ~~three~~six months ended ~~March~~June 3130, 2021:

Beginning balance, January 1, 2021	$	1,559,803
Amortization of debt discounts		2133,~~300~~750
Issuance of new convertible notes		—
Conversion of principal amounts outstanding into common stock of the Company		(4185,~~849~~852	)
Ending balance March 31, 2021	$	1,576,254
Ending balance June 30, 2021	$	1,407,701

On January 28, 2014, the Company converted $11,000 of a $22,000 convertible note to 245 common shares. The note had been purchased from a former officer of the Company based on the contractual conversion terms per agreement. The balance of this note was $8,263 at ~~March~~June 3130, 2021.

On January 5, 2015, the Company executed a promissory note for $20,000. The note bears interest at 6% and has a maturity date of January 5, 2016. It can be converted into common stock at a discount of 30% off of the conversion price. The conversion price is the average bid price on the 3 days prior to the date of conversion, but no less than $0.0001. This note was sold to a third party on August 21, 2015 and the terms of the notes were modified. The new note bears interest at 8% and has a maturity date of August 20, 2017. It can be converted into common stock at a discount of 45% off of the conversion price. The conversion price is the average of the three lowest bid prices during the 10 trading days prior to the date of conversion. The balance of this note was $~~20,000~~0 at ~~March~~June 3130, 2021.

On January 26, 2015, the Company executed a promissory note for $28,000. The note bears interest at 12% and has a maturity date of January 26, 2016. The note can be converted into common stock at a discount of 45% off of the conversion price. The conversion price is the average of the three lowest bid prices during the 10 trading days prior to the date of conversion, but no less than $0.0001. The balance of this note was $28,000 at ~~March~~June 3130, 2021.

On February 10, 2015, the Company executed a promissory note for $52,500. The note bears interest at 8% and has a maturity date of February 10, 2016. The note can be converted into common stock at a discount of 55% off of the conversion price. The conversion price is the average bid price on the 3 days prior to the date of conversion, but no less than $0.0001. The balance of this note was $~~3,600~~0 at ~~March~~June 3130, 2021.

On February 10, 2015, its holder sold dated June 30, 2014 a promissory note for $88,500 to a third-party investor and the terms of the note were modified. The note bears interest at 8% and has a maturity date of February 10, 2016. It can be converted into common stock at a discount of 55% off the conversion price. The conversion price is the average bid price on the 3 days prior to the date of conversion, but no less than $0.0001. On March 1, 2021, the holder converted $4,849 in note principal and $6,152 in accrued interest into 999,999 shares of the Company’s common stock. The balance of this note was $~~59,596~~ 0 at ~~March~~June 3130, 2021.

~~On February~~ -13, 2015, the Company executed a promissory note for $50,000. The note bears interest at 8% and has a maturity date of February 13, 2016. The note can be converted into common stock at a discount of 30% off of the conversion price. The conversion price is the average bid price on the 3 days prior to the date of conversion, but no less than $0.0001. This note was sold to a third party on August 21, 2015 and the terms of the notes were modified.-

On February 13, 2015, the Company executed a promissory note for $50,000. The note bears interest at 8% and has a maturity date of February 13, 2016. The note can be converted into common stock at a discount of 30% off of the conversion price. The conversion price is the average bid price on the 3 days prior to the date of conversion, but no less than $0.0001. This note was sold to a third party on August 21, 2015 and the terms of the notes were modified. The new note bears interest at 8% and has a maturity date of August 20, 2017. It can be converted into common stock at a discount of 45% off of the conversion price. The conversion price is the average of the three lowest bid prices during the 10 trading days prior to the date of conversion. The balance of this note was $~~52,966~~0 at ~~March~~June 3130, 2021.

On March 17, 2015, the Company executed a promissory note for $28,000. The note bears interest at 12% and has a maturity date of March 17, 2016. The note can be converted into common stock at a discount of 45% off of the conversion price. The conversion price is the average of the three lowest bid prices during the 10 trading days prior to the date of conversion, but no less than $0.0001. The balance of this note was $28,000 at ~~March~~June 3130, 2021.

On March 27, 2015, the Company executed a promissory note for $15,000. The note bears interest at 6% and has a maturity date of March 27, 2016. The note can be converted into common stock at a discount of 40% off of the conversion price. The conversion price is the average closing bid price on the three (3) days prior to the date of conversion. The balance of this note was $11,000 at ~~March~~June 3130, 2021.

On April 1, 2015, the Company executed a promissory note for $12,000. The note bears interest at 6% and has a maturity date of March 27, 2016. The note can be converted into common stock at a at a rate equivalent to the average closing bid price on the 3 days prior to the date of conversion. The balance of this note was $12,000 at ~~March~~June 3130, 2021.

On May 28, 2015, the Company executed a promissory note for $23,000. The note bears interest at 12% and has a maturity date of February 28, 2016. The note can be converted into common stock at a discount of 45% off of the conversion price. The conversion price is the average of the three lowest bid prices during the 20 trading days prior to the date of conversion. The balance of this note was $23,000 at ~~March~~June 3130, 2021.

On August 7, 2015, its holder sold two promissory notes aggregating $46,705 and originating in 2014 to a third-party investor and the terms of the notes were modified. The new note bears interest at 6% and has a maturity date of August 6, 2017. It can be converted into common stock at a discount of 45% off of the conversion price. The conversion price is the average of the three lowest bid prices during the 20 trading days prior to the date of conversion. The balance of this note was $46,705 at ~~March~~June 3130, 2021.

On August 21, 2015, the Company executed a promissory note for $30,000. The note bears interest at 6% and has a maturity date of August 21, 2016. The note can be converted into common stock at a discount of 40% off of the conversion price. The conversion price is the average closing bid price on the 3 days prior to the date of conversion. The balance of this note was $30,000 at ~~March~~June 3130, 2021.

9On August 24, 2015, the Company executed two (2) promissory notes, each in the principal amount of $15,000, for an aggregate $30,000. The notes bear interest at 6% and have a maturity date of August 24, 2016. The notes can be converted into common stock at a discount of 40% off of the conversion price. The conversion price is the average closing bid price on the 3 days prior to the date of conversion. The balance of these notes was $30,000 at June 30, 2021.

On ~~August~~September 242, 2015, the Company executed ~~two~~a ~~(2)~~ promissory ~~notes,~~note ~~each in the principal amount of $15,000,~~ for ~~an aggregate~~ $3051,~~000~~414. The ~~notes~~note ~~bear~~bears interest at 612% and ~~have~~has a maturity date of ~~August~~February 2428, 2016. The note ~~notes~~ can be converted into common stock at a discount of 4045% off of the conversion price. The conversion price is the average ~~closing~~of the three lowest bid ~~price~~prices onduring the 320 trading days prior to the date of conversion. The balance of ~~these~~this ~~notes~~ note was $3051,~~000~~414 at ~~March~~June 3130, 2021.

On September 24, 2015, the Company executed a promissory note for $5152,~~414~~500. The note bears interest at 128% and has a maturity date of ~~February~~September 284, ~~2016~~2017. ~~The note~~It can be converted into common stock at a discount of 45% off of the conversion price. The conversion price is the average of the three lowest bid prices during the 2010 trading days prior to the date of conversion. The balance of this note was $~~51,414~~0 at ~~March~~June 3130, 2021.

On September 4, 2015, the Company executed a promissory note for $52,500. The note bears interest at 8% and has a maturity date of September 4, 2017. It can be converted into common stock at a discount of 45% off of the conversion price. The conversion price is the average of the three lowest bid prices during the 10 trading days prior to the date of conversion. The balance of this note was $39,342 at March 31, 2021.-14-

During the year ended December 31, 2015, the Company received debt proceeds from the issuance of five convertible promissory notes aggregating $99,500 to certain lenders. The Company has attempted with no avail to locate these note agreements and validate the sources of these debt proceeds. It has exhausted all of its available resources in its efforts to locate these notes and note holders. As such, the Company has made certain assumptions in regard to the contractual terms associated with these notes, which are consistent with other convertible debt securities issued during the period. The balance of these notes was $99,500 at ~~March~~June 3130, 2021.

On January 1, 2018, the Company executed three promissory notes aggregating $693,819 to settle a legal matter. See Note 9 – Commitments and Contingencies. The notes bear interest at 12% and have a maturity date of July 10, 2018. The notes can be converted into common stock at a discount of 45% off of the conversion price. The conversion price is the lowest bid price during the 25 trading days prior to the date of conversion. On March 6, 2020, one of the holders entered into a note purchase and assignment agreement whereby $50,000 of note principal was sold to a third-party investor. The balance of these notes was $643,819 at ~~March~~June 3130, 2021.

On March 13, 2018, the Company issued a convertible promissory note for $5,500. The note bears interest at 12% and has a maturity date of March 13, 2020. The note can be converted into common stock at a discount of 50% off of the conversion price. The conversion price is equal to the lowest bid price during the 20 trading days prior to the date of conversion. The balance of this note was $~~5,500~~0 at ~~March~~June 3130, 2021.

On December 12, 2018, the Company issued a convertible promissory note for $25,000. The note bears interest at 8% and has a maturity date of December 12, 2020. The note can be converted into common stock at a discount of 40% off of the conversion price. The conversion price is equal to the lowest bid price during the five trading days prior to the date of conversion. The balance of this note was $25,000 at ~~March~~June 3130, 2021.

On March 6, 2020, as described above, a third-party investor purchased $50,000 in note principal from an existing noteholder pursuant to a note purchase and assignment agreement. On October 21, 2020, the holder converted $4,825 in note principal and $4,605 in accrued interest into 3,310,000 shares of the Company’s common stock. The balance of this note was $45,174 at ~~March~~June 3130, 2021.

On April 3, 2020, the Company issued a convertible promissory note for $35,000. The note bears interest at 12% and has a maturity date of December 31, 2020. The note can be converted into common stock at a discount of 45% off of the conversion price. The conversion price is the lowest bid price during the 25 trading days prior to the date of conversion. The balance of this note was $35,000 and ~~remaining~~all ~~unamortized discount~~related ~~was~~debt ~~$10,208~~discounts were fully amortized at ~~March~~June 3130, 2021.

On May 26, 2020, the Company issued a convertible promissory note for $15,000. The note bears interest at 12% and has a maturity date of February 26, 2021. The note can be converted into common stock at a discount of 50% off of the conversion price. The conversion price is equal to the lowest bid price during the 30 trading days prior to the date of conversion. The balance of this note was $15,000 and ~~remaining~~all ~~unamortized discount~~related ~~was~~debt ~~$6,875~~discounts atwere ~~March~~fully 31amortized at June 30, 2021.

On June 8, 2020, the Company issued a convertible promissory note for $11,200. The note was issued with an original issue discount of $1,200, or an effective interest rate of 12%, and has a maturity date of June 8, 2021. The note can be converted into common stock at a discount of 50% off of the conversion price. The conversion price is equal to the lowest bid price during the 20 trading days prior to the date of conversion. The balance of this note was $11,200 and ~~remaining~~all ~~unamortized~~related ~~discount~~debt ~~was~~discounts ~~$4,667~~were fully amortized at ~~March~~June 3130, 2021.

On August 12, 2020, the Company issued a convertible promissory note for $24,000. The note was issued with an original issue discount of $2,500, or an effective interest rate of 11.6%, and has a maturity date of August 12, 2021. The note can be converted into common stock at a discount of 50% off of the conversion price. The conversion price is equal to the lowest bid price during the 20 trading days prior to the date of conversion. The balance of this note was $24,000 and remaining unamortized discount was $142,000 at ~~March~~June 3130, 2021.

As of ~~March~~June 3130, 2021, most of the Company’s convertible promissory notes were in default of payment per the terms of their contractual maturity dates. To the best of its knowledge, the Company has not received any formal notices of default, demands for payment or other forms of claim as a result of these defaults. The Company is accruing interest on these convertible promissory notes at default rates ranging between 12% and 24%.

All of the convertible notes were analyzed at the time of their issuance for derivative accounting consideration. In some instances, the Company concluded that a derivative liability existed. The derivative liabilities were measured using the commitment-~~date stock price. As of March 31, 2021 and 2020, the Company determined that the fair value of these derivative liabilities totaled $2,460,803 and $2,298,820, respectively.~~15-

10All of the convertible notes were analyzed at the time of their issuance for derivative accounting consideration. In some instances, the Company concluded that a derivative liability existed. The derivative liabilities were measured using the commitment-date stock price. As of June 30, 2021 and December 31, 2020, the Company determined that the fair value of these derivative liabilities totaled $2,747,418 and $2,298,820, respectively.

The value of the derivative liabilities was determined using the following Black-Scholes methodology:

	March 31, 2021			December 31, 2020
Schedule of fair value of assumptions used
	June 30, 2021			December 31, 2020
Expected dividend yield (1)		0.0	%		0.0	%
Risk-free interest rate (2)		0.05 – 0.07	%		0.09 – 0.17	%
Expected volatility (3)		253.5 – 415.6	%		199.52 – 582.91	%
Expected life (in years)		0.5 – 1.0			0.5 – 1.0

______________

(1)	The Company has no history or expectation of paying cash dividends on its common stock.
(2)	The risk-free interest rate is based on the U.S. Treasury yield for a term consistent with the expected life of the promissory notes in effect at the time of issuance.
(3)	The volatility of the Company’s common stock is based on trading activity for the previous contractual term ended at each promissory note issuance date.

In accordance with ASC 470-20, Debt with Conversion and Other Options the Company records a beneficial conversion feature (“BCF”) related to the issuance of convertible debt or preferred stock instruments that have conversion features that are in-the-money when issued. The BCF for the convertible instruments is recognized and measured by allocating a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital. The intrinsic value is generally calculated at the commitment date as the difference between the conversion price and the fair value of the common stock or other securities into which the security is convertible, multiplied by the number of shares into which the security is convertible. If certain other securities are issued with the convertible security, the proceeds are allocated among the different components. The portion of the proceeds allocated to the convertible security is divided by the contractual number of the conversion shares to determine the effective conversion price, which is used to measure the BCF. The effective conversion price is used to compute the intrinsic value. The value of the BCF is limited to the basis that is initially allocated to the convertible security.

~~All~~At ofJune ~~the~~30, ~~convertible debentures were analyzed at the time of their issuance for a beneficial conversion feature. In some instances~~2021, the Company ~~concluded that~~did anot ~~beneficial~~have ~~conversion~~any ~~feature~~debt discounts ~~existed.~~related ~~The~~to beneficial conversion features ~~were measured using the commitment-date stock price and were determined to aggregate $698,819~~. This amount is recorded as a debt discount and is amortized as interest expense over the term of the related convertible debentures. The debt discounts were fully amortized as of March 31, 2021. No amortization expense was recorded for the three months ended March 31, 2021 and 2020, respectively.

At ~~March~~June 3130, 2021, the number of shares of common stock underlying these convertible debentures totaled 3671,~~218~~418,~~340~~784 shares.

NOTE 5 – STOCKHOLDERS’ EQUITY (DEFICIT)

Series A Preferred Stock

The authorized Series A preferred stock of the Company consists of 69,999,990 shares with a par value $0.00001. At ~~March~~June 3130, 2021 and December 31, 2020, the Company had 10,000,000 shares of its Series A preferred stock issued and outstanding. The majority of the Series A preferred stock entitles the stockholders to 67% overall voting rights.

Series D Preferred Stock

In April 2018, the Company designated and issued one (1) share of its preferred stock as “Series D”. The share is convertible into 8.70% of the Company’s then outstanding common stock, but no less than 8,500,000 shares of common stock subject to the satisfaction of certain conditions precedent. The holder is entitled to vote with the Company’s common stockholders, entitled to dividends, and certain liquidation rights. The Company, with the holder’s consent, may redeem the preferred share.

-16-

On June 15, 2020, the Company issued 8,700,000 shares of common stock upon the conversion of the share of Series D preferred stock.

On May 26, 2021, the Company amended the certificate of designation of its Series D to include a conversion feature whereby each holder of Series D preferred stock shall have the right to convert one share of Series D preferred stock into 5,000,000 shares of the Company’s common stock.

Series E Preferred Stock

The authorized Series E preferred stock of the Company consists of 50 shares with a par value $0.00001. At ~~March~~June 3130, 2021 and December 31, 2020, the Company had 4850 and 24 shares of its Series E preferred stock issued and outstanding, respectively.

On February 10, 2021, the Company issued 15 shares of Series E convertible preferred stock and 250,000 shares of common stock valued at $225,000 in lieu of cash for unpaid salary amounts to its chief executive officer. Additionally, the Company issued two of its officers an aggregate 6 shares of Series E convertible preferred stock and 100,000 shares of common stock valued at $90,000 as compensation.

On February 11, 2021, the Company issued 4 shares of Series E convertible preferred stock valued at $125,000 to a contractor for services rendered.

On March 1, 2021, the Company issued 2 shares of Series E convertible preferred stock pursuant to subscription agreements with accredited investors for proceeds of $40,000.

On June 14, 2021, the Company issued 2 shares of Series E convertible preferred stock and 200,000 shares of common stock pursuant to subscription agreements with accredited investors for proceeds of $20,000.

Common Stock

The authorized common stock of the Company consists of 1,000,000,000 shares with a par value $0.001. At ~~March~~June 3130, 2021 and December 31, 2020, the Company had ~~104~~123,~~141~~197,~~856~~371 and 101,~~925~~929,~~194~~ 993 shares of its common stock issued and outstanding, respectively.

On December 7, 2020, the Company and Giddy entered into a Settlement Agreement, Waiver and Release of Claims whereby each party warranted and represented that they sought to fully and mutually rescind the purchase agreement dated June 27, 2017 and, in so doing, for Giddy to acquire the assets previously sold and, at the same time, for each of the parties to waive and release all claims, both known and unknown, and to indemnify and hold all other parties harmless. On January 20, 2021, Giddy returned 2,000,000 shares of the Company’s common stock in connection with the agreement.

On February 11, 2021, the Company issued 1,200,000 shares of common stock to its chief executive officer in connection with the conversion of three (3) shares of Series E convertible preferred stock.

During the ~~three~~six months ended ~~March~~June 3130, 2021, the Company issued 14,~~666~~917,~~667~~381 shares of common stock pursuant to subscription agreements with accredited investors for proceeds of $~~100~~199,~~000~~380.

During the ~~three~~six months ended ~~March~~June 3130, 2021, the company issued ~~999~~16,799,999 shares of common stock in connection with the conversion of $4185,~~849~~852 in principal and $6505,~~152~~598 in accrued interest related to its convertible promissory notes.

These issuances were exempt from registration under rule 144.

11-17-

NOTE 6 – INCOME TAXES

As of ~~March~~June 3130, 2021, the Company had net operating loss carry forwards of approximately $15.2 7 million that may be available to reduce its tax liability through tax year 2039. The Company estimates the benefits of this loss carry forward at $3.23 million if it produces sufficient taxable income. No adjustments to the financial statements have been recorded for this potential tax benefit. The Company has no provisions from income tax in ~~2019~~2020, due to current period losses and full valuation allowance on deferred tax assets.

For the ~~three~~six months ended ~~March~~June 3130, 2021 and 2020, a reconciliation of the federal statutory rate of 21% to the Company’s effective tax rate is as follows:

	Three Months Ended March 31, 2021			Three Months Ended March 31, 2020
Schedule of income tax expense benefit
Expected expense (benefit) (21%)	$	(111,352	)	$	(3,675	)
	Six Months Ended June 30, 2021			Six Months Ended June 30, 2020
State income taxes, net of federal benefit		(25,134	)		(830	)
Expected expense (benefit) (21%)	$	(208,212	)	$	(616,050	)
Income tax provision (benefit)		(136,486	)		(4,505	)
State income taxes, net of federal benefit		(46,966	)		(139,051	)
Valuation allowance		136,486			4,505
Income tax provision (benefit)		(255,208	)		(755,101	)
Valuation allowance		255,208			755,101
Accrued expense (benefit)	$	—		$	—

The cumulative tax effect at the expected rate of 21% of significant items comprising the Company’s net deferred tax amount is as follows as of ~~March 31~~June 30, 2021 and December 31, 2020:

	March 31, 2021			December 31, 2020
Schedule of deferred tax
	June 30, 2021			December 31, 2020
Deferred tax asset attributable to:
Net operating loss carryover	$	3,~~192~~288,~~079~~939		$	3,080,727
Less: valuation allowance		(3,~~192~~288,~~079~~939	)		(3,080,727	)
Net deferred tax asset	$	—		$	—

Tax net operating loss carryforwards may be limited pursuant to the IRS Section 382 in the event of certain ownership changes.

NOTE 7 – FAIR VALUE MEASUREMENTS

The Company has adopted the guidance under ASC 820, Fair Value Measurements, for financial instruments measured on a fair value on a recurring basis. ASC 820 establishes a fair value hierarchy, giving the highest priority to quoted prices in active markets and the lowest priority to unobservable data and requires disclosures for assets and liabilities measured at fair value based on their level in the hierarchy. Further authoritative accounting guidance (ASU No. 2009-05, Measuring Liabilities at Fair Value) under ASC 820, provides clarification that in circumstances in which a quoted price in an active market for the identical liabilities is not available, a reporting entity is required to measure fair value using one or more of the techniques provided for in this update.

The standard describes a fair value hierarchy based on three levels of input, of which the first two are considered observable and the last unobservable, that may be used to measure fair value, which are the following:

•

Level 1 – Quoted prices in active markets for identical assets and liabilities.

•

Level 2 – Input other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets of liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liabilities.

•

Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.

The Company analyzes all financial instruments with features of both liabilities and equity under ASC 480, Distinguishing Liabilities from Equity and ASC 815, Derivatives and Hedging. Derivative liabilities are ~~adjusted to reflect fair value at each period end, with any increase or decrease in the fair value being recorded in results of~~ operations as adjustments to fair value of derivatives. The ~~effects~~ effects of interactions between embedded derivatives are calculated and accounted for in arriving at the over- all fair value of the ~~financial~~ financial instruments. In addition, the fair value of free-standing derivative instruments such as warrant and option derivatives are valued using the Black-Scholes modes.adjusted to reflect fair value at each period end, with any increase or decrease in the fair value being recorded in results of

-18-

The Company uses Level 3 inputs for its valuation methodology for the embedded conversion option liabilities as their fair value were determined by using the Black Scholes option-pricing model based on various assumptions. The Company’s derivative liabilities are adjusted to reflect fair value at each period end, with any increase or decrease in the fair value being recorded in results of operations as adjustments to fair value of derivatives.

The following table summarizes the change in the Company’s financial assets and liabilities measured at fair value as of December 31, 2020:

Schedule of Fair Value of Liabilities Measured on Recurring Basis
			Fair Value Measurements at Reporting Date Using
			Quoted prices in	Significant Other	Significant
			Active Markets for	Observable	Unobservable
			Identical Assets	Inputs	Inputs
Description	12/31/2020		(Level l)	(Level 2)	(Level 3)
Convertible promissory notes with embedded conversion option	$	2,298,820	—	—	$	2,298,820
Total	$	2,298,820	—	—	$	2,298,820

The following table summarizes the change in the Company’s financial assets and liabilities measured at fair value as of ~~March~~June 3130, 2021:

Fair Value Measurements at Reporting Date Using

Quoted prices in

Significant Other

Significant

Active Markets for

Observable

Unobservable

Identical Assets

Inputs

Description

0306/3130/2021

(Level l)

(Level 2)

(Level 3)

Convertible promissory notes with embedded conversion option

2,~~460~~747,~~803~~418

—

2,~~460~~747,~~803~~418

Total

2,~~460~~747,~~803~~418

—

2,~~460~~747,~~803~~418

The following table sets forth a summary of change in fair value of the Company’s derivative liabilities for the ~~three~~six months ended ~~March~~June 3130, 2021:

Schedule of Changes in Derivative Liabilities at Fair Value
Beginning balance, January 1, 2021	$	2,298,820
Change in fair value of embedded conversion features of convertible promissory notes included in earnings		~~161~~448,~~983~~598
Embedded conversion option liability recorded in connection with the issuance of convertible promissory notes		—
Ending balance, March 31, 2021	$	2,460,803
Ending balance, June 30, 2021	$	2,747,418

NOTE 8 – COMMITMENTS AND CONTINGENCIES

On September 23, 2020, the Company entered into a Merger Agreement and Plan of Reorganization (the “Acquisition Agreement”) with Human Brands International, Inc., a private corporation organized pursuant to the laws of the State of Nevada (“Human Brands”), pursuant to which, at the effective time, Human Brands shareholders will exchange 100% of the equity in Human Brands in exchange for a majority controlling interest in the Company. The agreement requires the Company to receive FINRA’s approval of a reverse stock split of its common stock. The agreement contains customary ~~terms~~ terms and conditions including completion of due diligence by the parties and approval by a majority of the Company’s shareholders and Human Brands shareholders.

On June 30, 2021, the Acquisition Agreement was made effective pending certain closing conditions. Under the terms of the Acquisition Agreement, the Company agreed to issue an aggregate of 45 shares of its Series D preferred stock and an aggregate of 176,771,962 shares of its common stock to acquire all of the outstanding capital stock of Human Brands.

NOTE 9 – SUBSEQUENT EVENTS

In accordance with FASB ASC 855-10, Subsequent Events, the Company has analyzed its operations subsequent to ~~March~~June 3130, 2021 to the date these condensed consolidated financial statements were issued, and has determined that it does not have any material subsequent events to disclose in these condensed consolidated financial statements, except for as follows:

On July ~~May 5~~1, 2021, ~~Union Capital, LLC (~~the ~~“Note~~Company ~~Holder”) agreed to exchange and surrender five promissory notes that were previously~~ issued ~~to the Note Holder with an aggregate principal amount of $271~~1,~~965 and (the “Prior Notes”) but presently having an unconverted balance of $185~~000,~~852 in principal and $318,350 in interest in exchange (the “Exchange Transaction”) for an aggregate of 10,900,~~000 shares of common stock pursuant to asubscription ~~Settlement~~agreements ~~Agreement,~~and ~~Waiver,~~received ~~Release~~proceeds of ~~Claims and Exchange Agreement dated April 26~~$20, ~~2021~~000.

13-19-

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion should be read in conjunction with our unaudited consolidated financial statements and notes thereto included herein. In connection with, and because we desire to take advantage of, the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, we caution readers regarding certain forward-looking statements in the following discussion and elsewhere in this report and in any other statement made by, or on our behalf, whether or not in future filings with the Securities and Exchange Commission. Forward looking statements are statements not based on historical information and which relate to future operations, strategies, financial results or other developments. Forward looking statements are necessarily based upon estimates and assumptions that are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control and many of which, with respect to future business decisions, are subject to change. These uncertainties and contingencies can affect actual results and could cause actual results to differ materially from those expressed in any forward-looking statements made by, or on our behalf. We disclaim any obligation to update forward looking statements.

Overview

Rogue One, Inc. (“Rogue One” or the “Company”) is a consumer products and marketing company focused on the high-margin, multi-trillion-dollar alcoholic beverages sector.

On September 23, 2020, the Company entered into a Merger Agreement and Plan of Reorganization with Human Brands International, Inc., a private corporation organized pursuant to the laws of the State of Nevada (“Human Brands”), pursuant to which, at the effective time, Human Brands shareholders will exchange 100% of the equity in Human Brands in exchange for a majority controlling interest in the Company. ~~Human~~On ~~Brands~~June ~~operating~~30, ~~divisions~~2021, ~~currently~~the ~~own~~Acquisition ~~and manage~~Agreement ~~over~~was ~~250,000~~made ~~agave~~effective ~~plants,~~pending ~~several~~certain ~~premium~~closing ~~spirit~~conditions. ~~brands,~~Under ~~and~~the ~~hold~~terms ~~exclusive~~of ~~import~~the ~~and~~Acquisition ~~export~~Agreement, the ~~rights~~Company ~~for~~agreed ato ~~variety~~issue an aggregate of ~~spirit brands.~~45 ~~Its~~shares ~~core~~of ~~foundation~~its isSeries ~~built~~D ~~upon~~preferred ~~its~~stock ~~bulk~~and ~~tequila~~an ~~production~~aggregate ~~operations.~~of ~~Human~~176,771,962 ~~Brands~~shares ~~currently~~of ~~has~~its ~~supply~~common stock ~~contracts~~to ~~with~~acquire ~~well-known tequila~~all ~~brands,~~of ~~celebrities~~the ~~and~~outstanding ~~athletes~~capital stock of Human Brands.

-20-

Results of Operations for the Three Months Ended ~~March~~June 3130, 2020 and 2019

Sales

We did not record any revenues for the three months ended ~~March~~June 3130, 2021 and 2020. We are contemplating various opportunities as a means to generate future sales revenue; however, we can provide no assurance that our efforts will successfully result in any new revenues.

Gross Profit

Gross profit is calculated by subtracting cost of goods sold from sales. Gross profit percentage is calculated by dividing gross profit by sales.

We did not record any cost of goods sold for either of the three months ended ~~March~~June 3130, 2021 and 2020. As such, we did not realize any gross profits during either of the three-month periods ended ~~March~~June 3130, 2021 and 2020.

Operating Expenses

Operating expenses totaled $~~289~~107,~~982~~742 for the three months ended ~~March~~June 3130, 2021, compared to $7540,~~674~~012 in operating expenses for the three months ended ~~March~~June 3130, 2020, or an increase of $~~214~~67,~~308~~730.

Our operating expenses are primarily comprised of compensation and benefits, professional fees and other general and administrative costs. The increase in operating expenses was due to increased compensation costs related to the addition of new executive management and stock-based compensation to employees and service providers. We expect our operating expenses to increase proportionally to our business activities as we begin to execute upon our business plan in future periods.

Other Income (Expense)

Net other ~~income~~ expense totaled $~~240~~353,~~266~~497 for the three months ended ~~March~~June 3130, 2021, compared to $582,~~173~~876,058 in net other ~~income~~expense for the three months ended ~~March 31~~June 30, 2020, or a decrease of $~~298~~2,~~439~~522,561.

The Company has issued various convertible notes to help finance its operations, some of which have embedded derivative features. The value of these instruments will fluctuate as the trading price of our common stock changes. During the three months ended ~~March~~June 3130, 2021, recorded an unrealized loss of $~~161~~286,~~983~~615 from the increase in value of these derivative features, compared to an unrealized ~~gain~~loss of $~~113~~2,~~585~~706,281 from the change in the value of these derivative features during the three months ended ~~March~~June 3130, 2020.

14During the three months ended June 30, 2021, we recorded interest expense related to the amortization of debt discounts totaling $12,450, compared to $ 10,933 during the three months ended June 30, 2020. During the three months ended June 30, 2020, we accrued interest expense on convertible notes or $53,182, compared to interest expense of $55,412 during the three months ended June 30, 2019.

During the three months ended March 31, 2021, we recorded interest expense related to the amortization of debt discounts totaling $0, compared to $5,541 during the three months ended March 31, 2020. During the three months ended March 31, 2020, we accrued interest expense on convertible notes or $56,983, compared to interest expense of $55,412 during the three months ended March 31, 2019.

Net Loss

We incurred a net loss of $~~530~~461,~~248~~239, or $0.0100 per share, for the three months ended ~~March~~June 3130, 2021, compared to a net loss of $172,~~501~~916,070, or $0.0003 per share, for the three months ended ~~March~~June 3130, 2020.

The weighted average number of basic and fully diluted shares outstanding for the three months ended ~~March~~June 3130, 2021 was ~~102~~116,~~120~~934,~~193~~786, compared to 8696,~~381~~515,~~861~~927 for the three months ended ~~March 31,~~June 30, 2020. There are no dilutive equivalents included in our calculation of fully diluted shares for the three months ended ~~March~~June 3130, 2021, since their inclusion would be anti-dilutive due to our net loss per share.

-21-

Results of Operations for the Six Months Ended June 30, 2021 and 2020

Sales

We did not record any revenues for the six months ended June 30, 2021 and 2021. While we believe that our new focus will create opportunities that will generate future revenue for the Company, we can provide no assurance that we will be successful in the execution of our business plan.

Gross Profit

We did not record any cost of goods sold for either of the six months ended June 30, 2021 and 2020. As such, we did not realize any gross profit during either of the six-month periods ended June 30, 2021 and 2020.

Operating Expenses

Operating expenses totaled $397,724 for the six months ended June 30, 2021, compared to $115,686 in operating expenses for the six months ended June 30, 2020, or an increase of $282,038.

Our operating expenses are primarily comprised of compensation and benefits, professional fees and other general and administrative costs. The increase in operating expenses was due to the timing of services rendered in relation to our financial reporting and fees incurred from various state compliance filings. We expect our operating expenses to increase proportionally to our business activities as we begin to execute upon our business plan in future periods.

Other Income (Expense)

Net other expense totaled $593,763 for the six months ended June 30, 2021, compared to $2,817,885 in net other expense for the six months ended June 30, 2020, or an increase in net other expense of $2,224,122.

The Company has issued various convertible notes to help finance its operations, some of which have embedded derivative features. The value of these instruments will fluctuate as the trading price of our common stock changes. During the six months ended June 30, 2021, we recorded an unrealized loss of $448,598 from the increase in value of these derivative features, compared to a non-cash derivative expense of $102,248 and experienced an unrealized loss of $2,592,696 from the increase in value of these derivative features during the six months ended June 30, 2020.

During the six months ended June 30, 2021, we recorded interest expense related to the amortization of debt discounts totaling $33,750, compared to $10,933 during the six months ended June 30, 2020. During the six months ended June 30, 2021, we accrued interest expense on convertible notes or $110,165, compared to interest expense of $112,031 during the six months ended June 30, 2020.

Net Loss

We incurred a net loss of $991,487, or $0.01 per share, for the six months ended June 30, 2021, compared to a net loss of $2,933,571, or $0.03 per share, for the six months ended June 30, 2020.

The weighted average number of basic and fully diluted shares outstanding for the six months ended June 30, 2021 was 109,572,911, compared to 87,098,894 for the six months ended June 30, 2020. There are no dilutive equivalents included in our calculation of fully diluted shares for the six months ended June 30, 2021 and 2020, since their inclusion would be anti-dilutive due to our net loss per share.

-22-

Liquidity and Capital Resources

The accompanying unaudited financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the ordinary course of business.

The Company sustained a net loss of $~~530~~991,~~248~~487 for the ~~three~~six months ended ~~March~~June 3130, 2021. Because of the absence of positive cash flows from operations, the ~~Company~~ Company requires additional funding to execute upon its business plan. These factors raise substantial doubt about the Company’s ~~ability~~ ability to continue as a going concern. The accompanying condensed consolidated financial statements do not include any adjustments that ~~might~~ might result from the outcome of this uncertainty.

We are presently unable to meet our obligations as they come due. At ~~March~~June 3130, 2021, we had cash and cash equivalents totaling $~~2,129~~216 and a working capital deficit of $5,~~602~~329,~~593~~002. Our working capital deficit is primarily due to the balance of our convertible notes payable and related derivative liabilities.

During the ~~three~~six months ended ~~March~~June 3130, 2021, net cash used in operating activities was $~~137~~271,~~982~~775, compared to $5059,963 of cash provided by operating activities for the ~~three~~six months ended ~~March 31~~June 30, 2020. During the ~~three~~six months ended ~~March~~June 3130, 2021, net cash provided by financing activities was $~~140~~271,~~000~~ 880 compared, to $060,000 of cash provided by financing activities for the ~~three~~six months ended ~~March~~June 3130, 2020.

We anticipate that our cash requirements will arise from the need to fund our growth from operations, pay current obligations and future capital expenditures. The primary sources of funding in the near term for such requirements are expected to be cash generated from raising additional funds by the issuance of convertible notes. However, we can provide no assurances that we will be able to generate sufficient cash flow or obtain additional financing on terms satisfactory to us if at all, to remain a going concern. Our continuation as a going concern is dependent upon our ability to generate sufficient cash flow to meet our obligations on a timely basis and ultimately to attain profitability. In addition, our plan for the next twelve months is to raise capital to continue to expand our operations. We are presently engaged in capital raising activities through one or more private offerings of our company’s securities. See “Note 2– Going Concern” in our financial statements for additional information as to the possibility that we may not be able to continue as a “going concern.”

Inflation

Although our operations are influenced by general economic conditions, we do not believe that inflation had a material effect on our results of operations during the nine-month period ended ~~March~~June 3130, 2021.

Off-Balance Sheet Arrangements

WeNot ~~had no off-balance sheet arrangements as of March 31, 2021 and December 31, 2020~~applicable.

Critical Accounting Estimates

Our financial statements and accompanying notes have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires management to make estimates, judgments and assumptions that affect reported amounts of assets, liabilities, revenues and expenses. We continually evaluate the accounting policies and estimates used to prepare the condensed financial statements. The estimates are based on historical experience and assumptions believed to be reasonable under current facts and circumstances. Actual amounts and results could differ from these estimates made by management. Certain accounting policies that require significant management estimates and are deemed critical to our results of operations or financial position are discussed in our Annual Report on Form 10-K for the year ended December 31, 2020 in the Critical Accounting Policies section of Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Not applicable

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures designed to provide reasonable assurance that information required to be disclosed in reports filed under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the specified time periods and accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding disclosure.

Our management, with the participation of our Chief Executive Officer (“CEO”) and our Chief Financial Officer (“CFO”), evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-~~15(e) and 15d~~23-15(e) promulgated under the Exchange Act) as of March 31, 2021. In designing and evaluating disclosure controls and procedures, we and our management recognize that any disclosure controls and procedures, no matter how well designed and operated, can only provide reasonable assurance of achieving the desired control objective. As of March 31, 2021, based on the evaluation of these disclosure controls and procedures, and in light of the material weaknesses found in our internal controls, the CEO and CFO concluded that our disclosure controls and procedures were not effective.

InOur ~~light~~management, of with the ~~conclusion that~~participation of our ~~internal~~Chief ~~controls~~Executive ~~over~~Officer ~~financial~~(“CEO”) ~~reporting~~and ~~were~~our ~~ineffective~~Chief asFinancial ofOfficer ~~March 31~~(“CFO”), ~~2021,~~evaluated wethe effectiveness ~~have~~of ~~applied~~our ~~procedures~~disclosure controls and ~~processes~~procedures (as ~~necessary~~ todefined ~~ensure~~in ~~the~~Rules ~~reliability~~13a-15(e) ofand ~~our~~15d-15(e) ~~financial~~promulgated ~~reporting~~under inthe ~~regards~~Exchange toAct) as ~~this~~of ~~quarterly~~June ~~report~~30, on2021. ~~Form~~In ~~10-Q.~~designing ~~Accordingly,~~and ~~management believes,~~evaluating ~~based~~disclosure oncontrols ~~its~~and ~~knowledge~~procedures, ~~that:~~we ~~(i)~~and ~~this~~our ~~quarterly~~management ~~report~~recognize ~~does~~that ~~not~~any ~~contain~~disclosure controls ~~any~~and ~~untrue~~procedures, ~~statement~~no ofmatter ahow ~~material~~well ~~fact~~designed orand ~~omit~~operated, ~~to state~~can aonly ~~material~~provide ~~fact~~reasonable ~~necessary~~assurance toof ~~make~~achieving the ~~statements~~desired ~~made,~~control objective. inAs ~~light~~ of ~~the~~June ~~circumstances~~30, ~~under which they were made~~2021, ~~not~~based ~~misleading with~~on ~~respect to~~ the ~~periods~~evaluation ~~covered~~of bythese ~~this~~disclosure ~~report;~~controls and ~~(ii) the financial statements~~procedures, and ~~other~~in ~~financial~~light ~~information~~of ~~included~~the inmaterial ~~this~~weaknesses ~~quarterly report,~~found ~~fairly present~~ in ~~all material respects~~ our ~~financial~~internal ~~condition~~controls, ~~results~~the ofCEO ~~operations~~ and ~~cash~~CFO ~~flows~~concluded asthat ~~at,~~our ~~and for,~~disclosure ~~the~~controls ~~periods~~and ~~presented~~procedures inwere ~~this~~not ~~quarterly report~~effective.

In light of the conclusion that our internal controls over financial reporting were ineffective as of June 30, 2021, we have applied procedures and processes as necessary to ensure the reliability of our financial reporting in regards to this quarterly report on Form 10-Q. Accordingly, management believes, based on its knowledge, that: (i) this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which they were made, not misleading with respect to the periods covered by this report; and (ii) the financial statements, and other financial information included in this quarterly report, fairly present in all material respects our financial condition, results of operations and cash flows as at, and for, the periods presented in this quarterly report.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting during the last quarterly period covered by this report that have materially affected, or are reasonably likely to affect, our internal control over financial reporting.

16-24-

PART II — OTHER INFORMATION

Item 1. Legal Proceedings.

We are not currently involved in any litigation that we believe could have a materially adverse effect on our financial condition or results of operations. Except as set forth above, there is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our Company or any of our subsidiaries, threatened against or affecting our Company, our common stock, any of our subsidiaries or of our Company’s or our Company’s subsidiaries’ officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect.

Item 1A. Risk Factors

There have been no material changes to the risk factors disclosed in “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on April 21, 2021.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On ~~February~~April 1014, 2021, the Company issued ~~350~~4,900,000 shares of common stock to ~~officers~~a asnote ~~compensation~~holder upon the conversion of $147,185 of accrued interest on a convertible note.

On ~~February~~April 2216, 2021, the Company issued 1525,~~200,000~~714 shares of common stock pursuant to asubscription ~~shareholder~~agreements ~~upon~~and ~~the~~received ~~conversion~~proceeds of ~~three shares of preferred stock~~$18,400.

On ~~February~~April 2316, 2021, the Company issued 1125,~~666,667~~000 shares of common stock pursuant to subscription agreements and received proceeds of $~~100~~4,~~000~~990.

On ~~March~~April 121, 2021, the Company issued ~~999~~1,~~999~~275,000 shares of common stock pursuant to asubscription ~~note~~agreements ~~holder~~and ~~upon~~received ~~the~~proceeds ~~conversion~~ of $1351,~~636 in convertible note principal and $1,364 of accrued interest~~000.

On May 5, 2021, the Company issued 10,900,000 shares of common stock to a note holder upon the conversion of $181,003 in convertible note principal and $352,262 of accrued interest.

On May 13, 2021, the Company issued 125,000 shares of common stock pursuant to subscription agreements and received proceeds of $4,990.

On June 2, 2021, the Company issued an aggregate 1,000,000 shares of common stock pursuant to subscription agreements and received proceeds of $20,000.

On June 14, 2021, the Company issued 200,000 shares of common stock and 2 shares of Series E preferred stock pursuant to subscription agreements and received proceeds of $20,000.

The above issuances did not involve any underwriters, underwriting discounts or commissions, or any public offering and we believe is exempt from the registration requirements of the Securities Act of 1933 by virtue of Section 4(2) thereof and/or Regulation D promulgated thereunder.

Item 3. Defaults upon Senior Securities

None.

Item 5. Other Information

None.

Item 6. Exhibits

31.1	Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer

31.2	Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer

32	Chief Executive Officer and Chief Financial Officer Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS		XBRL Instance Document*
101.SCH		XBRL Schema Document*
101.CAL		XBRL Calculation Linkbase Document*
101.DEF		XBRL Definition Linkbase Document*
101.LAB		XBRL Label Linkbase Document*
101.PRE		XBRL Presentation Linkbase Document*

________________

-25-

* Pursuant to Rule 406T of Regulation S-T, these interactive data files are not deemed filed or part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act or Section 18 of the Securities Exchange Act and otherwise not subject to liability.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Quarterly Report to be signed on its behalf by the undersigned thereunder duly authorized.

	ROGUE ONE, INC.
Date: May 24, 2021	By:	/s/ Joe E. Poe, Jr.
Date: August 23, 2021	By:	/s/ Joe E. Poe, Jr.
	Name:	Joe E. Poe, Jr.
	Title:	Chief Executive Officer
		(Principal Executive Officer)

18-26-

Filing Compare · Rogue One, Inc.